GR3022915T3 - Novel orally-active elastase inhibitors - Google Patents

Novel orally-active elastase inhibitors

Info

Publication number
GR3022915T3
GR3022915T3 GR970400601T GR970400601T GR3022915T3 GR 3022915 T3 GR3022915 T3 GR 3022915T3 GR 970400601 T GR970400601 T GR 970400601T GR 970400601 T GR970400601 T GR 970400601T GR 3022915 T3 GR3022915 T3 GR 3022915T3
Authority
GR
Greece
Prior art keywords
elastase inhibitors
active elastase
novel orally
novel
orally
Prior art date
Application number
GR970400601T
Other languages
English (en)
Inventor
Norton P Peet
Michael R Angelastro
Joseph P Burkhart
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of GR3022915T3 publication Critical patent/GR3022915T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
GR970400601T 1991-08-22 1997-03-26 Novel orally-active elastase inhibitors GR3022915T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74860791A 1991-08-22 1991-08-22

Publications (1)

Publication Number Publication Date
GR3022915T3 true GR3022915T3 (en) 1997-06-30

Family

ID=25010166

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970400601T GR3022915T3 (en) 1991-08-22 1997-03-26 Novel orally-active elastase inhibitors

Country Status (16)

Country Link
EP (1) EP0529568B1 (el)
JP (1) JP3311392B2 (el)
KR (1) KR100242046B1 (el)
AT (1) ATE147756T1 (el)
AU (1) AU655831B2 (el)
CA (1) CA2076307C (el)
DE (1) DE69216713T2 (el)
DK (1) DK0529568T3 (el)
ES (1) ES2099186T3 (el)
FI (1) FI923787A (el)
GR (1) GR3022915T3 (el)
HU (1) HU208703B (el)
IL (1) IL102858A (el)
NO (1) NO308999B1 (el)
NZ (1) NZ243998A (el)
ZA (1) ZA926185B (el)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714470A (en) * 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
ATE161271T1 (de) * 1992-07-29 1998-01-15 Merrell Pharma Inc Peptide als lungensurfactant und therapeutisch wirksame mischungen
ATE157671T1 (de) * 1992-07-31 1997-09-15 Merrell Pharma Inc Synthetische peptide als lungensurfactants mit kovalent gebundenen antioxidantien
US5977074A (en) * 1993-10-01 1999-11-02 Merrell Pharmaceuticals, Inc. Inhibitors of β-amyloid protein production
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
US5439888A (en) * 1994-03-04 1995-08-08 Eli Lilly And Company Antithrombotic agents
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5436229A (en) * 1994-03-04 1995-07-25 Eli Lilly And Company Bisulfite adducts of arginine aldehydes
US5488037A (en) * 1994-03-04 1996-01-30 Eli Lilly And Company Antithrombotic agents
US5484772A (en) * 1994-03-04 1996-01-16 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
JPH09510442A (ja) * 1994-03-11 1997-10-21 ファーマコペイア，インコーポレイテッド スルホンアミド誘導体及びそれらの使用
NZ284766A (en) * 1994-06-02 1998-06-26 Merrell Pharma Inc Perfluoro amino ketones; medicaments as elastase inhibitors
DE69531459T2 (de) * 1994-06-02 2004-06-24 Aventis Pharmaceuticals Inc. Elatase-inhibitoren
ES2161293T3 (es) * 1994-06-02 2001-12-01 Merrell Pharma Inc Derivados de enol acilados como profarmacos de inhibidores de la elastasa.
US5998379A (en) * 1994-11-21 1999-12-07 Cortech Inc. Serine protease inhibitors-proline analogs
US6100238A (en) * 1994-11-21 2000-08-08 Cortech Inc. Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors
US6159938A (en) * 1994-11-21 2000-12-12 Cortech, Inc. Serine protease inhibitors comprising α-keto heterocycles
US6001811A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors--N-substituted derivatives
US6150334A (en) * 1994-11-21 2000-11-21 Cortech, Inc. Serine protease inhibitors-tripeptoid analogs
US20020119985A1 (en) 1994-11-21 2002-08-29 Albert Gyorkos Serine protease inhibitors
US6001814A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors
US6015791A (en) * 1994-11-21 2000-01-18 Cortech Inc. Serine protease inhibitors-cycloheptane derivatives
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US6001813A (en) * 1994-11-21 1999-12-14 Cortech Inc. Val-pro containing α-keto oxadiazoles as serine protease inhibitors
US5691368A (en) * 1995-01-11 1997-11-25 Hoechst Marion Roussel, Inc. Substituted oxazolidine calpain and/or cathepsin B inhibitors
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
KR100343553B1 (ko) * 1995-03-23 2002-10-31 에스케이케미칼주식회사 열가소성폴리에테르에스테르블록공중합체조성물
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US6656910B2 (en) 1997-12-04 2003-12-02 Cortech, Inc. Serine protease inhibitors
IL139761A0 (en) * 1998-05-20 2002-02-10 Expression Genetics Inc A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier
JP2003520185A (ja) 1998-06-03 2003-07-02 コーテック インコーポレーテッド セリンプロテアーゼ阻害剤としてのα−ケトオキサジアゾール類
WO2013152170A1 (en) 2012-04-04 2013-10-10 Catylix, Inc. Selective androgen receptor modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318318A1 (en) * 1987-11-27 1989-05-31 Sensititre Limited Urine assay process and kit
AU661270B2 (en) * 1990-03-05 1995-07-20 Cephalon, Inc. Chymotrypsin-like proteases and their inhibitors
KR920701200A (ko) * 1990-03-30 1992-08-11 미즈노 시게루 신규의 4h-3,1-벤조옥사진-4-온 유도체

Also Published As

Publication number Publication date
HU208703B (en) 1993-12-28
EP0529568B1 (en) 1997-01-15
ES2099186T3 (es) 1997-05-16
DK0529568T3 (da) 1997-02-03
NO923280L (no) 1993-02-23
KR100242046B1 (ko) 2000-03-02
ATE147756T1 (de) 1997-02-15
FI923787A0 (fi) 1992-08-21
NO923280D0 (no) 1992-08-21
FI923787A (fi) 1993-02-23
JP3311392B2 (ja) 2002-08-05
HUT62014A (en) 1993-03-29
IL102858A0 (en) 1993-01-31
IL102858A (en) 1998-12-27
CA2076307A1 (en) 1993-02-23
EP0529568A1 (en) 1993-03-03
AU655831B2 (en) 1995-01-12
DE69216713T2 (de) 1997-05-28
NZ243998A (en) 1994-11-25
NO308999B1 (no) 2000-11-27
CA2076307C (en) 2003-01-07
ZA926185B (en) 1993-03-01
KR930004280A (ko) 1993-03-22
JPH05213991A (ja) 1993-08-24
DE69216713D1 (de) 1997-02-27
AU2106592A (en) 1993-02-25

Similar Documents

Publication Publication Date Title
GR3022915T3 (en) Novel orally-active elastase inhibitors
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
IL116078A (en) Substituted heterocyclic compounds capable of inhibiting serine proteases and pharmaceutical compositions containing them
IS4695A (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar
NZ237023A (en) 17beta-substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions
DK0805796T3 (da) Celleadhæsionsinhiberende forbindelser
CA2163361A1 (en) Therapeutic substituted guanidines
ATE227293T1 (de) 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one
NO944946L (no) Forgrenet-amino-substituerte tiazoler, fremgangsmåter for fremstilling av dem og farmasöytiske blandinger inneholdende dem
IL113940A (en) Synthetic peptides which are elastase inhibitors and pharmaceutical compositions for the treatment of neutrophil associated inflammatory disease containing said inhibitors
ZA979647B (en) Heterocyclic compounds, compositions and uses.
ATE223376T1 (de) Bisarylcyclobutenderivate als cyclooxygenasehemmer
PL328225A1 (en) Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
DE69726743D1 (de) Peptid analoge, die einen siebengliedrigen lactamring enthalten
ZA979645B (en) Heterocyclic compounds, compositions and uses.
ZA979650B (en) Heterocyclic compounds, compositions and uses.
ATE100463T1 (de) Renin-hemmende aminooligohydroxy-derivate.
ITMI931174A0 (it) Composizioni farmaceutiche per la cura della talassemia
CA2073673A1 (en) Esters of 2-arylmethyl-1-naphthol derivatives as 5-lipoxygenase inhibitors